PMID- 28705449
OWN - NLM
STAT- MEDLINE
DCOM- 20190729
LR  - 20190729
IS  - 2542-4513 (Print)
IS  - 2542-4513 (Linking)
VI  - 42
IP  - 1
DP  - 2017 Feb
TI  - [Venous thromboembolic disease: Comparison of management practices in France, 
      Italy and Spain].
PG  - 6-13
LID - S2542-4513(17)30011-1 [pii]
LID - 10.1016/j.jdmv.2017.01.002 [doi]
AB  - BACKGROUND: Many national and international guidelines have been established for 
      venous thromboembolic disease (VTE). Homogeneous management practices could be 
      expected in the different European countries. To verify this hypothesis, we 
      compared practices in France, Italy and Spain. METHOD: We used data from the 
      international RIETE registry to compare VTE management between France, Italy and 
      Spain. RESULTS: From 2001 January to 2011 January, patients were consecutively 
      included in France (n=1548), Italy (n=2083) and Spain (29,824). All patients 
      received anticoagulant treatment. Low molecular-weight heparin (LMWH) was the 
      most frequently used drug as initial therapy in all three countries, but 
      unfractionated heparin (UFH) was more frequently used in France and Italy than in 
      Spain. In France, the proportion of patients receiving LMWH was lower than the 
      proportion of patients with active cancer (cancer 22.5 %, long-term treatment 
      with LMWH 17.4 %). A vena cava filter was significantly more frequently used in 
      France (5.5 % in France, 3.2 % in Italy and 2 % in Spain, P<0.0001). High 
      bleeding risk because of surgery with recent thromboembolic disease was the most 
      frequent indication in France and Italy for vena cava filter placement (36.4 %, 
      and 31.3 %, respectively). CONCLUSION: Despite the publication of national and 
      international guidelines, VTE management differs among the three major European 
      countries included in the RIETE registry, France, Italy and Spain.
CI  - Copyright (c) 2017 Elsevier Masson SAS. All rights reserved.
FAU - Maurizot, A
AU  - Maurizot A
AD  - Service de medecine vasculaire, hopital de Rangueil, CHU de Toulouse, 1, avenue 
      du Professeur-Jean-Poulhes, TSA 50032, 31059 Toulouse cedex 9, France; 
      Consultations de medecine vasculaire, Centre cardiologique du Nord, 32-36, rue 
      des Moulins-Gemeaux, 93200 Saint-Denis, France. Electronic address: 
      doc.maurizot@gmail.com.
FAU - Bura-Riviere, A
AU  - Bura-Riviere A
AD  - Service de medecine vasculaire, hopital de Rangueil, CHU de Toulouse, 1, avenue 
      du Professeur-Jean-Poulhes, TSA 50032, 31059 Toulouse cedex 9, France.
FAU - Gritli, K
AU  - Gritli K
AD  - Service de medecine vasculaire, hopital de Rangueil, CHU de Toulouse, 1, avenue 
      du Professeur-Jean-Poulhes, TSA 50032, 31059 Toulouse cedex 9, France; Centre de 
      consultation medicale specialisee Delta Medical, rue Habib Chatti, Manar II, 
      Tunis, Tunisie.
FAU - Bertoletti, L
AU  - Bertoletti L
AD  - SAINBIOSE, DVH, Inserm, departement de medecine et therapeutique, hopital Nord, 
      CHU de Saint-Etienne, 42055 Saint-Etienne cedex 2, France.
FAU - Hernandez-Blasco, L
AU  - Hernandez-Blasco L
AD  - ISABIAL, Department of Clinical Medicine, Universidad Miguel Hernandez, Hospital 
      General Universitario Alicante, Alicante, Espagne.
FAU - Ciammaichella, M
AU  - Ciammaichella M
AD  - Department of Emergency Internal Medicine, Ospedale St. John, Rome, Italie.
FAU - Diaz-Pedroche, M C
AU  - Diaz-Pedroche MC
AD  - Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, 
      Espagne.
FAU - Alfonso, M
AU  - Alfonso M
AD  - Department of Pneumonology, Complejo Hospitalario de Navarra, Pamplona, Espagne.
FAU - Lorente, M A
AU  - Lorente MA
AD  - Department of Internal Medicine. Hospital de la Agencia Valenciana de Salud Vega 
      Baja, Alicante, Espagne.
FAU - Monreal, M
AU  - Monreal M
AD  - Department of Internal Medicine, Hospital Universitario Germans Trias i Pujol de 
      Badalona, Universidad Catolica de Murcia, Murcia, Espagne.
CN  - RIETE Investigators
LA  - fre
PT  - Comparative Study
PT  - Journal Article
TT  - Comparaison en France, en Italie et en Espagne des modalites de prise en charge 
      de la maladie thromboembolique veineuse.
DEP - 20170418
PL  - France
TA  - J Med Vasc
JT  - Journal de medecine vasculaire
JID - 101709200
RN  - 0 (Anticoagulants)
RN  - 0 (Heparin, Low-Molecular-Weight)
MH  - Aged
MH  - Anticoagulants/*therapeutic use
MH  - Female
MH  - France
MH  - Heparin, Low-Molecular-Weight/*therapeutic use
MH  - Humans
MH  - Italy
MH  - Male
MH  - Middle Aged
MH  - Practice Patterns, Physicians'/statistics & numerical data
MH  - Spain
MH  - Venous Thromboembolism/*drug therapy
OTO - NOTNLM
OT  - Filter cava
OT  - Filtre cave
OT  - Heparine de bas poids moleculaire
OT  - Low molecular weight heparin
OT  - Maladie thromboembolique veineuse
OT  - Venous thromboembolism disease
EDAT- 2017/07/15 06:00
MHDA- 2019/07/30 06:00
CRDT- 2017/07/15 06:00
PHST- 2016/06/14 00:00 [received]
PHST- 2016/11/25 00:00 [accepted]
PHST- 2017/07/15 06:00 [entrez]
PHST- 2017/07/15 06:00 [pubmed]
PHST- 2019/07/30 06:00 [medline]
AID - S2542-4513(17)30011-1 [pii]
AID - 10.1016/j.jdmv.2017.01.002 [doi]
PST - ppublish
SO  - J Med Vasc. 2017 Feb;42(1):6-13. doi: 10.1016/j.jdmv.2017.01.002. Epub 2017 Apr 
      18.